1-7 of 7
Yajing Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

OL-101, a BCMA/GPRC5D dual-targeting autologous CAR-T for relapsed/ refractory multiple myeloma (R/R MM): Results from a Phase I study

Free
Yongxian Hu, Mingming Zhang, Yajing Zhang, Shan Fu, Jingjing Feng, Guoai Su, Dan Song, Chia-Wei Chang, Hongmei Wang, Sihui Guan, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2387.
https://doi.org/10.1182/blood-2025-2387
Published: 2025
Journal Articles

Direct IL-6 sequestration with siltuximab rescues CAR T-cell proliferation from inflammatory suppression: A longitudinal multi-omic analysis supporting a paradigm shift in CRS management

Free
Ruijie He, Xuelin Han, Chen Chen, Shilin Gan, Guoai Su, Peihao Zheng, Huihui Zhao, Fangfang Cheng, Yue Wu, Yajing Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2386.
https://doi.org/10.1182/blood-2025-2386
Published: 2025
Journal Articles

Sequential BCMA and GPRC5D CAR-T cell therapy combined with an optimizing bridging regimen for Relapsed/Refractory multiple myeloma with bulky/extensive extramedullary disease: A synergistic integration approach

Free
Fangfang Cheng, Guoai Su, Peihao Zheng, Huihui Zhao, Yue Wu, Xuelin Han, Yajing Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 255.
https://doi.org/10.1182/blood-2025-255
Published: 2025
Journal Articles

Unveiling the “second wave”: Viral-triggered biphasic CAR-T expansion drives late-onset IEC-HS: Characterization and successful management

Free
Guoai Su, Peihao Zheng, Xuelin Han, Huihui Zhao, Yue Wu, Fangfang Cheng, Yajing Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5948.
https://doi.org/10.1182/blood-2025-5948
Published: 2025
Journal Articles

Prolonged thrombocytopenia following diverse CAR-T cell therapies: High incidence, inflammatory risk factors, and a comparative efficacy analysis of TPO-receptor agonist strategies in a real-world cohort

Free
Guoai Su, Peihao Zheng, Xuelin Han, Ruijie He, Huihui Zhao, Yue Wu, Fangfang Cheng, Yajing Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 4169.
https://doi.org/10.1182/blood-2025-4169
Published: 2025
Journal Articles

Outcome of Tandem CD19/CD20 CAR Therapy with 3-Year Follow-up in R/R B-NHL

Free
Yajing Zhang, Zhiqiang Wu, Yao Wang, Qingming Yang, Yang Liu, Chuan Tong, Weidong Han
Journal: Blood
Blood (2022) 140 (Supplement 1): 4606–4607.
https://doi.org/10.1182/blood-2022-166844
Published: 2022
Journal Articles

Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma

Free
Clinical Trials & Observations
Chuan Tong, Yajing Zhang, Yang Liu, Xingyu Ji, Wenying Zhang, Yelei Guo, Xiao Han, Dongdong Ti, Hanren Dai, Chunmeng Wang, Qingming Yang, Wanli Liu, Yao Wang, Zhiqiang Wu, Weidong Han
Journal: Blood
Blood (2020) 136 (14): 1632–1644.
https://doi.org/10.1182/blood.2020005278
Published: 2020
Includes: Supplemental data